(FMC) FMC - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3024913036
FMC: Insecticides, Herbicides, Fungicides, Biologicals, Fertilizers
FMC Corporation is a leading player in the agricultural sciences sector, specializing in crop protection, plant health, and professional pest management solutions. The company has a robust portfolio that includes insecticides, herbicides, fungicides, and biological products, all designed to enhance crop yields and quality. Their offerings are not just limited to agriculture; they also serve non-agricultural markets for pest control, showcasing their versatility and broad market reach.
With a strong emphasis on innovation, FMC invests significantly in research and development to stay ahead in the competitive agrochemical industry. Their product line extends to crop nutrition and seed treatments, which are essential for modern farming practices. This comprehensive approach underscores their commitment to sustainability and efficiency in agriculture.
FMCs global presence is a testament to their extensive distribution network. They operate across North America, Latin America, Europe, the Middle East, Africa, and Asia, with a distribution strategy that includes direct sales, alliances, and independent partners. This wide reach allows them to cater to diverse markets and maintain a strong position in high-growth regions.
Financially, FMC presents an attractive profile for investors. With a market capitalization of $4.45 billion, the company demonstrates stability and scale. The P/E ratio of 11.11 indicates a reasonable valuation, while the forward P/E of 10.10 suggests potential growth. A P/B ratio of 1.0 aligns the stock closely with its book value, appealing to value investors. The P/S ratio of 1.07 highlights efficient revenue generation relative to the companys size.
Overall, FMC Corporations strategic focus on innovation, global distribution, and a balanced financial position makes it a compelling investment opportunity in the agricultural sciences sector. Their commitment to sustainability and broad product range positions them well for long-term growth and market resilience.
Additional Sources for FMC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FMC Stock Overview
Market Cap in USD | 4,634m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 1985-07-01 |
FMC Stock Ratings
Growth Rating | -59.6 |
Fundamental | 16.5 |
Dividend Rating | 67.4 |
Rel. Strength | -24.8 |
Analysts | 3.74/5 |
Fair Price Momentum | 34.09 USD |
Fair Price DCF | 106.14 USD |
FMC Dividends
Dividend Yield 12m | 4.97% |
Yield on Cost 5y | 3.13% |
Annual Growth 5y | 5.21% |
Payout Consistency | 99.0% |
FMC Growth Ratios
Growth Correlation 3m | -27.6% |
Growth Correlation 12m | -61.3% |
Growth Correlation 5y | -54.1% |
CAGR 5y | -12.55% |
CAGR/Max DD 5y | -0.17 |
Sharpe Ratio 12m | -0.53 |
Alpha | -36.73 |
Beta | 0.809 |
Volatility | 34.06% |
Current Volume | 0k |
Average Volume 20d | 2008.7k |
As of April 19, 2025, the stock is trading at USD 37.84 with a total of 0 shares traded.
Over the past week, the price has changed by +1.99%, over one month by -10.42%, over three months by -29.63% and over the past year by -30.49%.
Neither. Based on ValueRay Fundamental Analyses, FMC is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.46 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FMC as of April 2025 is 34.09. This means that FMC is currently overvalued and has a potential downside of -9.91%.
FMC has received a consensus analysts rating of 3.74. Therefor, it is recommend to hold FMC.
- Strong Buy: 7
- Buy: 1
- Hold: 10
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, FMC FMC will be worth about 36.8 in April 2026. The stock is currently trading at 37.84. This means that the stock has a potential downside of -2.7%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 49.3 | 30.3% |
Analysts Target Price | 69.5 | 83.7% |
ValueRay Target Price | 36.8 | -2.7% |